Related Experiment Video
Updated: Aug 11, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
[Obesity and the heart]
1IRCCS Policlinico San Matteo--Pavia, Presidio di Belgioioso.
Insights
Obesity independently increases heart disease risk. Weight loss improves cardiovascular health by reducing blood pressure, glucose, cholesterol, and left ventricular mass.
Area of Science:
- Cardiology
- Metabolic Syndrome
Context:
- Obesity is an independent risk factor for coronary heart disease and congestive heart failure.
- Cardiac structure and function can be altered in morbid obesity, independent of hypertension or organic heart disease.
Purpose:
- To explore the link between obesity, cardiac dysfunction, and cardiovascular disease.
- To understand the mechanisms of obesity cardiomyopathy and associated metabolic risk factors.
Summary:
- Obesity leads to increased blood volume and high cardiac output, potentially causing ventricular dilatation and eccentric hypertrophy, termed obesity cardiomyopathy.
- This can result in diastolic and systolic dysfunction, leading to congestive heart failure.
- Central obesity, insulin resistance, and metabolic syndrome (Syndrome X) are key factors linking obesity to ischemic heart disease.
Impact:
- Weight loss is crucial for obese patients, reducing mortality and morbidity from coronary heart disease.
- Weight reduction can delay or prevent congestive heart failure and improve cardiac structure and function.
- Losing weight positively impacts blood pressure, glucose levels, lipid profiles, and left ventricular mass.
Abstract:
Obesity has been identified as an independent risk factor for coronary heart disease and congestive heart failure. Although congestive heart failure can be secondary to coronary heart disease, in morbid obesity these conditions can be independent. Cardiac structure and function can be altered even in the absence of systemic hypertension and underlying organic heart disease. In obese patients total blood volume increases and creates a high cardiac output state that may cause ventricular dilatation and ultimately eccentric hypertrophy of the left (and possibly the right) ventricle. Eccentric left ventricular hypertrophy produces diastolic dysfunction. Systolic dysfunction may ensue due to excessive wall stress if wall thickening fails to keep pace with dilatation. This disorder is referred to as obesity cardiomyopathy. The frequent coexistence of systemic hypertension in obese individuals facilitates development of left ventricular dilatation and hypertrophy. Congestive heart failure may occur and may be attributable to left ventricular diastolic dysfunction or to combined diastolic and systolic dysfunction. The risk of coronary heart disease seems to be more strictly correlated to central obesity than to increased body mass index. Insulin resistance seems to be the key factor that links obesity and ischaemic heart disease. In such a condition the so called Syndrome X appears. It is characterized by: obesity, systemic hypertension, diabetes mellitus, hypertriglyceridaemia and reduced HDL cholesterol levels. Considering that left ventricular hypertrophy is often present, many risk factors coexist in obese patients. Weight loss is very useful in obese patients. It may reduce mortality and morbidity for coronary heart disease and delay or avoid the appearance of congestive heart failure. It is proved that after weight loss, blood pressure, glucose, cholesterol, triglycerides and left ventricular mass decrease.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Heart Failure II: Pathophysiology
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology